![](_page_0_Picture_1.jpeg)

## Evidence Tables **B**

| First Author<br>and Year | Volume/Method                                                                       | n  | r                    | Regression Equation                                                                    | SEE                     | Standard of<br>Reference                     |
|--------------------------|-------------------------------------------------------------------------------------|----|----------------------|----------------------------------------------------------------------------------------|-------------------------|----------------------------------------------|
| Schiller 1979            | Modified Simpson's rule<br>Diastolic volume<br>Systolic volume<br>Ejection fraction | 30 | 0.80<br>0.90<br>0.87 | Echo = 0.7 angio − 1 mL<br>Echo = 0.7 angio − 2 mL<br>Echo = angio + 5%                | 15 mL<br>8.5 mL<br>7.6% |                                              |
| Folland 1979             | Modified Simpson's rule<br>Ejection fraction                                        | 35 | 0.78                 | Angio = 1.01 echo + 0.04                                                               | 9.7%                    | Single-plane<br>angio                        |
|                          | Ejection fraction                                                                   |    | 0.75                 | Radionuclide = 0.75 echo + 0.07                                                        | 8.7%                    | Radionuclide                                 |
| Parisi 1979              | Modified Simpson's rule<br>Diastolic volume<br>Systolic volume<br>Ejection fraction | 50 | 0.82<br>0.90<br>0.80 | Angio = 1.08 echo + 30 mL                                                              | 39 mL<br>29 mL<br>9%    | Single-plane<br>angio                        |
| Silverman<br>1980        | Biplane area-length<br>Diastolic volume<br>Systolic volume<br>Ejection fraction     | 20 | 0.96<br>0.91<br>0.82 | Echo = 1.05 angio − 3.64<br>Echo = 1.37 angio − 1.37<br>Echo = 9.87 angio + 0          |                         | Biplane angio                                |
| Starling 1981            | Simpson's rule<br>Diastolic volume<br>Systolic volume<br>Ejection fraction          | 70 | 0.80<br>0.88<br>0.90 | Echo = 0.66 angio + 42 mL<br>Echo = 0.72 angio + 18 mL<br>Echo = 0.76 angio + 12%      | 34 mL<br>27 mL<br>7%    | Single or<br>biplane (n =<br>30) LV<br>angio |
| Quinones<br>1981         | Simplified method<br>Ejection fraction                                              | 55 | 0.93<br>0.91         |                                                                                        | 6.7%<br>7.4%            | Radionuclide<br>Angio                        |
| Tortoledo<br>1983        | Simplified method<br>Diastolic volume<br>Systolic volume<br>Ejection fraction       | 52 | 0.88<br>0.94<br>0.92 | Angio = 1.07 echo − 7.3 mL<br>Angio = 1.0 echo + 1.3 mL<br>Angio = 0.93 echo + 3.5 mL  | 28 mL<br>19 mL<br>7%    | Single-plane<br>angio                        |
| Erbel 1983               | Simpson's rule<br>Diastolic volume<br>Systolic volume<br>Ejection fraction          | 46 | 0.91<br>0.94<br>0.80 | Echo = 0.66 angio + 0.8 mL<br>Echo = 0.57 angio + 18 mL<br>Echo = 0.61 angio + 13%     | 26 mL<br>19 mL<br>9%    | Single-plane<br>LV angio                     |
| Zoghbi 1990              | Echo-tilt method<br>Diastolic volume<br>Systolic volume<br>Ejection fraction        | 24 | 0.92<br>0.96<br>0.82 | Angio = 0.80 echo + 37 mL<br>Angio = 0.97 echo − 1 mL<br>Angio = 1.17 echo − 4%        | 23 mL<br>16 mL<br>10%   | Biplane angio                                |
| Smith 1992               | TEE Simpson's rule<br>Diastolic volume<br>Systolic volume<br>Ejection fraction      | 36 | 0.85<br>0.94<br>0.85 | Echo = 0.75 angio + 0.2 mL<br>Echo = 0.78 angio − 3.5 mL<br>Echo = 0.82 angio + 9.0 mL | 42 mL<br>22 mL<br>8%    | LV angio<br>(single<br>plane)                |

*Angio,* Angiography; *SEE,* standard error of the estimate.

Data from Schiller et al: *Circulation* 60:547–555, 1979; Folland et al: *Circulation* 60:760–766, 1979; Parisi et al: *Clin Cardiol* 2:257–263, 1979; Silverman et al: *Circulation* 62:548–557, 1980; Starling et al: *Circulation* 63:1075–1084, 1981; Quinones et al: *Circulation* 64:744–753, 1981; Tortoledo et al: *Circulation* 67:579–584, 1983; Erbel et al: *Circulation* 67:205–215, 1983; Zoghbi et al: *J Am Coll Cardiol* 15:610–617, 1990; Smith et al: *J Am Coll Cardiol* 19:1213–1222, 1992.

| Table B.2<br>Selected Clinical Studies Validating 3D Echocardiographic LV Volume Measurements |                                          |     |                                                                                                           |                                                                                |                          |  |  |
|-----------------------------------------------------------------------------------------------|------------------------------------------|-----|-----------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------|--------------------------|--|--|
| First Author<br>and Year                                                                      | Method                                   | n   | r                                                                                                         | Limits of Agreement<br>SEE                                                     | Standard of<br>Reference |  |  |
| Gopal 1993                                                                                    | Normal adults                            | 15  | EDV 0.92<br>ESV 0.81                                                                                      | 7 mL<br>4 mL                                                                   | CMR                      |  |  |
| Sapin 1994                                                                                    | Patients (mean<br>age 48 yr)             | 35  | EDV 0.97<br>ESV 0.98                                                                                      | 11.0 mL<br>10.2 mL                                                             | LV angio                 |  |  |
| Gopal 1997                                                                                    | Patients with<br>abnormal LV             | 30  | EDV 0.90<br>ESV 0.93                                                                                      | 31.8 mL<br>24.1 mL                                                             | CMR                      |  |  |
| Kuehl 1998                                                                                    | Patients                                 | 24  | EDV 0.9<br>ESV 0.94<br>EF 0.93                                                                            | 23.9<br>17.2<br>7.0 mL                                                         | LV angio                 |  |  |
| Mele 1998                                                                                     | Patients                                 | 50  | EDV 0.95<br>ESV 0.96<br>EF 0.92                                                                           | 15.2<br>11.4<br>6.2 mL                                                         | LV angio, RN,<br>CMR     |  |  |
| Qin 2000                                                                                      | Patients (13 with<br>LV aneurysms)       | 29  | LV volumes<br>r = 0.97                                                                                    | −28 mL (mean difference)                                                       | CMR                      |  |  |
| Lee 2001                                                                                      | Patients                                 | 25  | EDV 0.99<br>ESV 0.99<br>EF 0.92                                                                           | 11.3 mL<br>10.2 mL<br>6%                                                       | CMR                      |  |  |
| Kawai 2003                                                                                    | Patients                                 | 15  | EDV 0.94<br>ESV 0.96<br>EF 0.93                                                                           | EDV 21.6 mL<br>ESV 14.8 mL<br>EF 7.6%                                          | CT                       |  |  |
|                                                                                               |                                          |     |                                                                                                           | Bland-Altman Analysis*                                                         |                          |  |  |
| Jenkins 2004                                                                                  | RT 3D                                    | 50  | EDV 0.98<br>ESV 0.99<br>EF 0.92<br>LV mass 0.87                                                           | 0 ± 5 mL<br>1 ± 4 mL<br>0 ± 2%<br>0 ± 13 g                                     | CMR                      |  |  |
| Jenkins 2006                                                                                  | RT 3D                                    | 110 | Online analysis<br>EDV 0.78<br>ESV 0.86<br>EF 0.64<br>Offline analysis<br>EDV 0.86<br>ESV 0.91<br>EF 0.81 | −44 ± 35 ml<br>−21 ± 28 mL<br>−2 ± 10%<br>−15 ± 28 mL<br>10 ± 22 mL<br>−1 ± 8% | CMR                      |  |  |
| Soliman 2008                                                                                  | RT 3D                                    | 24  | EDV 0.98<br>ESV 0.98<br>EF 0.97<br>LV mass 0.98                                                           | −0.1 ± 19.8 mL<br>−4.2 ± 8.3 mL<br>0.2 ± 6.2%<br>−5.8 ± 15.4 mL                | CMR                      |  |  |
| Muraru 2010                                                                                   | RT 3D                                    | 23  | EDV 0.98<br>ESV 0.98<br>EF 0.95                                                                           | −2.7 (−14.9 + 9.5) mL<br>−1.7 (−9.8 + 6.4) mL<br>−0.1 −4.8 + 5.1)              | CMR                      |  |  |
| Macron 2010                                                                                   | RT 3D (2-beats)                          | 66  | EDV 0.94<br>ESV 0.96<br>EF 0.92                                                                           | −17 ± 21 mL<br>−9 ± 16 ml<br>1 ± 6%                                            | CMR                      |  |  |
| Marsan 2011                                                                                   | RT 3D in patients<br>with LV<br>aneurysm | 52  | EDV 0.97<br>ESV 0.98<br>EF 0.97                                                                           | 21.6 ± 40.4 mL<br>19.8 ± 40.1 mL<br>−0.9 ± 4.5%                                | CMR                      |  |  |
| Chang 2011                                                                                    | RT 3D (single<br>beat)                   | 109 | EDV 0.91<br>ESV 0.94<br>EF 0.91                                                                           | 41.4 ± 36.5 mL<br>−7.91 ± 33.1 mL<br>−8.26 ± 12.8%                             | CMR                      |  |  |
| Aurich 2014                                                                                   | RT 3D                                    | 47  | EF 0.74 (2D<br>auto-EF)<br>EF 0.73 (3D)                                                                   | 9 ± 17%<br>9 ± 17%                                                             | CMR                      |  |  |
| Yang 2016                                                                                     | RT 3D (single<br>beat)                   | 34  | EDV 0.93<br>ESV 0.95<br>EF 0.91                                                                           | −31.8 ± 25.8 mL<br>−28.5 ± 28.2 mL<br>6.4 ± 6.3%; Y                            | CMR (same day)           |  |  |

## TABLE B.2 Selected Clinical Studies Validating 3D Echocardiographic LV Volume Measurements—cont'd

\*Bias and limits of agreement by Bland-Altman.

*angio,* Angiography; *CMR,* cardiac magnetic resonance imaging; *CT,* computed tomography; *DOP,* Doppler; *EDV,* end-diastolic volume; *ESV,* end-systolic volume; *RN,* radionuclide angiography; *RT,* real-time; *SEE,* standard error of the estimate. Data from Gopal et al: *J Am Coll Cardiol* 22:258–270, 1993; Sapin et al: *J Am Coll Cardiol* 24:1054, 1994; Gopal et al: *J Am Soc Echocardiogr* 10:853, 1997; Kuehl et al: *J Am Soc Echocardiogr* 11: 1113–1124, 1998; Mele et al: 11:1001, 1998; Qin et al: *J Am Coll Cardiol* 36:900–907, 2000; Lee et al: *J Am Soc Echocardiogr* 14:1001–1009, 2001; Kawai et al: *J Am Soc Echocardiogr* 16:11011–11015, 2003; Jenkins et al: *J Am Coll Cardiol* 18:878–886, 2004; Jenkins et al: *J Am Soc Echocardiogr* 19:1119–1128, 2006; Soliman et al: *Am J Cardiol* 15:778–783, 2008; Muraru et al: *Eur J Echocardiogr* 11:359–368, 2010; Macron et al: *Circ Cardiovasc Imaging* 3:450–455, 2010; Marson et al: *Ann Thorac Surg* 91:113–121, 2011; Chang et al: *J Am Soc Echocardiogr* 24:853–859, 2011;Aurich et al: *J Am Soc Echocardiogr* 27(10):1017–1024, 2014; Yang et al: *J Am Soc Echocardiogr* 29(9):853–860, 2016. See also Dorosz JL, Lezotte DC, Weitzenkamp DA, et al: Performance of 3-dimensional echocardiography in measuring left ventricular volumes and ejection fraction: a systematic review and meta-analysis, *J Am Coll Cardiol* 59(20):1799–1808, 2012.

| Table B.3                | Selected Studies Validating Doppler Volume Flow Measurement |                                     |                      |                                                             |                                     |                                           |
|--------------------------|-------------------------------------------------------------|-------------------------------------|----------------------|-------------------------------------------------------------|-------------------------------------|-------------------------------------------|
| First Author<br>and Year | Volume Flow Site<br>and Method                              | n                                   | r                    | Regression<br>Equation                                      | SEE                                 | Standard of<br>Reference                  |
| Huntsman<br>1983         | Ascending aorta                                             | 100                                 | 0.94                 | DOP = 0.95x + 0.38                                          | 0.58 L/min                          | TD CO                                     |
| Fisher 1983              | Mitral leaflets                                             | 52                                  | 0.97                 | DOP = 0.98x + 0.02                                          | 0.23 L/min                          | Roller pump                               |
| Meijboom<br>1983         | Mitral leaflets                                             | 26                                  | 0.99                 | DOP = 0.97x + 0.07                                          | 0.13 L/min                          | EM flow and<br>roller pump                |
|                          | RVOT                                                        | 26                                  | 0.99                 | DOP = 0.96x + 0.11                                          | 0.16 L/min                          | Roller pump                               |
| Lewis 1984               | Mitral annulus<br>LVOT                                      | 35<br>39                            | 0.96<br>0.95         | TD = 0.91x + 5.1<br>TD = 0.91x + 7.8                        | 5.9 mL<br>6.4 mL                    | TD SV<br>TD SV                            |
| Stewart<br>1985          | Mitral leaflets<br>Aortic annulus<br>Pulmonary annulus      | 29<br>33<br>30                      | 0.97<br>0.98<br>0.93 | DOP = 0.98x + 0.3<br>DOP = 1.06x + 0.2<br>DOP = 0.89x + 0.4 | 0.3 L/min<br>0.3 L/min<br>0.5 L/min | Roller pump<br>Roller pump<br>Roller pump |
| Bouchard<br>1987         | Aortic leaflets                                             | 41                                  | 0.95                 | DOP = 0.97x + 1.7                                           | 7 mL                                | TD SV                                     |
| Dittmann<br>1987         | Mitral annulus<br>LVOT (M-mode)                             | 40<br>40                            | 0.86<br>0.93         | DOP = 0.88 + 1.75<br>DOP = 0.94x + 0.44                     | 0.80 L/min<br>0.59 L/min            | TD CO<br>TD CO                            |
| DeZuttere<br>1988        | Mitral<br>orifice(instantaneous)                            | 30                                  | 0.91                 | DOP = 0.92x + 0.35                                          | 0.53 L/min                          | TD CO                                     |
| Hoit 1988                | Mitral leaflets                                             | 48                                  | 0.93                 | DOP = 1.1x − 0.45                                           | 0.36 L/min                          | TD CO                                     |
| Otto 1988                | LVOT (proximal to<br>aortic stenosis)                       | 52                                  | 0.91                 | DOP = 1.0x + 0.03                                           | 0.25 L/min                          | EM flow and<br>timed<br>collection        |
| Burwash<br>1993          | LVOT (proximal to<br>aortic stenosis)                       | 75                                  | 0.86                 | Flow probe CO =<br>0.92 DOP + 0.26                          | 0.50 L/min                          | Transit-time<br>flow probe                |
| Lefrant 2000             | Ascending aorta                                             | 58 patients<br>(314 paired<br>data) | 0.84                 | DOP = 0.84 TD +<br>1.39                                     |                                     | TD CO                                     |
| Gentles<br>2001          | Ascending aorta                                             | 20 children with<br>complex CHD     | 0.96                 | DOP = 0.98<br>Fick − 0.08 mL                                |                                     | Fick CO                                   |
| Chandraratna<br>2002     | Pulmonary artery<br>(continuous)                            | 50 ICU patients                     | 0.92                 | DOP = 0.93<br>TD + 0.60                                     | 0.7 L/min                           | TD CO                                     |

*CHD,* Congenital heart disease; *CO,* cardiac output; *DOP,* Doppler; *EM,* electromagnetic flow meter; *ICU,* intensive care unit; *LVOT,* left ventricular outflow tract; *RVOT,* RV outflow tract; *SEE,* standard error of the estimate; *SV,* stroke volume; *TD,* thermodilution. Data from Huntsman et al: *Circulation* 67:593–601, 1983; Fisher et al: *Circulation* 67:872–877, 1983; Meijboom et al: *Circulation* 68:437– 445, 1983; Lewis et al: *Circulation* 70:425–431, 1984; Stewart et al: *J Am Coll Cardiol* 6:653–662, 1985; Bouchard et al: *J Am Coll Cardiol* 9:75–83, 1987; Dittman et al: *J Am Coll Cardiol* 10:818–823, 1987; DeZuttere et al: *J Am Coll Cardiol* 11:343–350, 1988; Hoit et al: *Am J Cardiol* 62:131–135, 1988; Otto et al: *Circulation* 78:435–441, 1988; Burwash et al: *Am J Physiol* 265:H1734–H1743, 1993; Lefrant et al: *Intensive Care Med* 26:693–697, 2000; Gentles et al: *J Ultrasound Med* 20:365-370, 2001; Chandraratna et al: *J Am Soc Echocardiogr* 15:1381–1386, 2002.

TABLE B.4 Selected Studies Validating Noninvasive Pulmonary Artery Pressure Measurement Compared With Direct Measurement by Right Heart Catheterization

| First Author and<br>Year      | Method                                                      | n   | r                            | Regression Equation                                                                                                                                                                                              | SEE                                                                                               |  |  |  |  |
|-------------------------------|-------------------------------------------------------------|-----|------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------|--|--|--|--|
| Pulmonary Artery Pressure     |                                                             |     |                              |                                                                                                                                                                                                                  |                                                                                                   |  |  |  |  |
| Kitabatake 1983               | Time to peak flow<br>(RVOT)                                 | 33  | −0.88                        | Log(mean PAP) = 0.0068 (AcT)<br>+ 2.1 mmHg                                                                                                                                                                       | —                                                                                                 |  |  |  |  |
| Stevenson 1989                | TR-jet<br>Time to peak flow (PA)<br>IVRT<br>PR              | 50  | 0.96<br>0.63<br>0.97<br>0.96 | —                                                                                                                                                                                                                | 6.9 mmHg<br>16.4 mmHg<br>5.4 mmHg<br>4.5 mmHg                                                     |  |  |  |  |
| Yock 1984                     | TR jet                                                      | 62  | 0.95                         | Doppler ΔP RV<br>= 1.03 ΔP +<br>− RA<br>0.71 mmHg                                                                                                                                                                | 7 mmHg                                                                                            |  |  |  |  |
| Berger 1985                   | TR jet                                                      | 69  | 0.97                         | PAPSystolic<br>= 1.23 (DOP ΔP)<br>− 0.09 mmHg                                                                                                                                                                    | 4.9 mmHg                                                                                          |  |  |  |  |
| Currie 1985                   | TR jet                                                      | 127 | 0.96                         | DOP ΔPRV-RA<br>= 0.88 ΔP + 2.2<br>mmHg                                                                                                                                                                           | 7 mmHg                                                                                            |  |  |  |  |
| Pepi 1994                     | TR jet with RA pressure<br>based on IVC                     | 110 | 0.99                         | —                                                                                                                                                                                                                | 5.4 mmHg                                                                                          |  |  |  |  |
| Lee 1989                      | PR                                                          | 29  | 0.94                         | DOP PAPDiastolic<br>= 0.95 (cath)<br>− 1.0 mmHg                                                                                                                                                                  | Mean difference: 3.3<br>± 2.2 mmHg                                                                |  |  |  |  |
| Chandraratna<br>2002          | PR                                                          | 50  | 0.91                         | DOP PAPDiastolic<br>= 0.82 (cath) +<br>0.96                                                                                                                                                                      | 3.3 mmHg                                                                                          |  |  |  |  |
| Aduen 2009*                   | Mean PAP by TR jet<br>TR mean ΔP<br>Peak PR velocity        | 102 |                              | Bland Altman<br>−1.5 (−1.2 to 4.3) mmHg<br>6.1 (4.0 to 8.1) mmHg<br>−5.6 (−7.8 to −3.4) mmHg                                                                                                                     | Median % difference<br>17%<br>21%<br>28%                                                          |  |  |  |  |
| Er 2010                       | Mean PAP by TR mean<br>ΔP                                   | 164 | 0.93                         | Bland Altman<br>0.3 (+12 to −12) mmHg                                                                                                                                                                            | PAPmean<br>≥25.5 mmHg<br>98% accurate<br>for pulmonary<br>hypertension                            |  |  |  |  |
| Aduen 2011                    | Mean PAP byTR mean<br>ΔP                                    | 117 |                              | Doppler versus catheter mean<br>PAP mean difference −1.6 ±<br>7.7 mmHg                                                                                                                                           | Accuracy (calculated<br>PAPmean within 10<br>mmHg) was 81%                                        |  |  |  |  |
| Nagueh 2011                   | PASP, PADP, RAP, LV<br>SV in patients with<br>heart failure | 79  |                              | Stroke volume: r = 0.83<br>(P < 0.001)<br>PA systolic pressure (TR jet):<br>r = 0.83 (P < 0.001)<br>PA diastolic pressure (PR jet):<br>r = 0.51 (P = 0.009)<br>RA pressure (IVC method):<br>r = 0.85 (P < 0.001) |                                                                                                   |  |  |  |  |
| Pulmonary Vascular Resistance |                                                             |     |                              |                                                                                                                                                                                                                  |                                                                                                   |  |  |  |  |
| Gurudevan 2007                | Systolic velocity<br>tricuspid annulus<br>(tSm)             | 50  | −0.71                        | PVR = 3698 − 1227 × ln(tSm)<br>dyne-s-cm−5                                                                                                                                                                       | tSm<br>>10 has a<br>sensitivity of 80%<br>and specificity of<br>100% for PVR<br>>1000 dyne-s-cm−5 |  |  |  |  |
| Abbas 2003                    | VTR/VTIRVOT                                                 | 44  | 0.93                         | PVR = (VTR/VTIRVOT) × 10 + 0.16                                                                                                                                                                                  | SD 0.0 ± 0.41 Wood<br>units                                                                       |  |  |  |  |
| Farzaneh-Far<br>2008          | VTR/VTIRVOT                                                 | 22  | 0.70                         | (VTR/VTIRVOT) > 0.12 predicts<br>PVR >1.5 Wood units                                                                                                                                                             | Sensitivity 100%<br>Specificity 86%                                                               |  |  |  |  |

*AcT,* Acceleration time; *DOP,* Doppler; *IVC,* inferior vena cava; *IVRT,* isovolumic relaxation time; *ΔP,* pressure gradient; *PA,* pulmonary artery; *PADP,* pulmonary artery diastolic pressure; *PAP,* pulmonary artery pressure; *PASP,* pulmonary artery systolic pressure; *PR,* pulmonic regurgitation; *PVR,* pulmonary vascular resistance; *RAP,* right atrial pressure; *SEE,* standard error of the estimate; *SV,* stroke volume; *TR,* tricuspid regurgitation, *V,* velocity; *VTI,* velocity-time integral.

<span id="page-3-0"></span><sup>\*</sup>Contrast enhanced Doppler signals, Bland Altman shown as mean difference (95% limits of agreement). Data from Kitabatake et al: *Circulation* 68:302-309, 1983; Stevenson et al: *J Am Soc Echocardiogr* 2:157–171, 1989; Yock et al: *Circulation* 70:657–662, 1984; Berger et al: *J Am Coll Cardiol* 6:359–365, 1985; Currie et al: *J Am Coll Cardiol* 6:750–756, 1985; Pepi et al: *J Am Soc Echocardiogr* 7(1):20–26, 1994; Lee et al: *Am J Cardiol* 64:1366–1370, 1989; Chandraratna et al: *J Am Soc Echocardiogr* 15:1381–1386, 2002; Aduen et al: *J Am Soc Echocardiogr* 22: 814–819, 2009; Er et al: *PLoS One* 5(12):e15670, 2010; Aduen et al: *Chest* 139:347–532, 2011; Nagueh et al: *Circ Cardiovasc Imaging* 4:220–227, 2011; Gurudevan et al: *J Am Soc Echocardiogr* 20:1167–1171, 2007; Abbas et al: *J Am Coll Cardiol* 41 1021-1027, 2003; Farzeneh-Far et al: *Am J Cardiol* 101:259–262, 2008.

| Table B.5                       | Selected Studies Validating Doppler Measures of LV Filling Pressures |       |                                                                                                               |                    |                    |                       |  |  |
|---------------------------------|----------------------------------------------------------------------|-------|---------------------------------------------------------------------------------------------------------------|--------------------|--------------------|-----------------------|--|--|
| Echo<br>Parameter               | Reference<br>Standard                                                | r     | Breakpoints                                                                                                   | Sensitivity<br>(%) | Specificity<br>(%) | Reference             |  |  |
| Transmitral Flow                |                                                                      |       |                                                                                                               |                    |                    |                       |  |  |
| E/A                             | PAWP                                                                 | 0.72  | E/A >1.1 predicts PAWP >12 mmHg                                                                               |                    |                    | Appleton 1993         |  |  |
| E/A                             | LVEDP                                                                |       | E/A >2.0 associated with LVEDP<br>>20 mmHg                                                                    | 100                | 100                | Channer 1986          |  |  |
| DT                              | PAWP                                                                 | −0.90 | DT ≤120 ms predicts PAWP<br>≥20 mmHg                                                                          | 100                | 99                 | Giannuzzi 1994        |  |  |
| DT                              | LVEDP                                                                | −0.74 | DT <140 ms predicts LVEDP<br>≥20 mmHg                                                                         | 90                 | 99                 | Cecconi 1996          |  |  |
| DT                              | LAP                                                                  | 0.73  | DT <180 ms predicts LAP<br>≥20 mmHg                                                                           | 100                | 100                | Nishimura 1996        |  |  |
| ΔA-velocity<br>with<br>Valsalva | LVEDP                                                                | 0.85  | ↓A-wave by 21 ± 15 cm/s with LVEDP<br><15 mmHg↑A-wave by 18 ±<br>13 cm/s with LVEDP >25 mmHg                  |                    |                    | Schwammenthal<br>2000 |  |  |
| Pulmonary Vein Flow             |                                                                      |       |                                                                                                               |                    |                    |                       |  |  |
| adur                            | LVEDP                                                                |       | adur<br>>0.35 m/s predicts LVEDP<br>>15 mmHg                                                                  |                    |                    | Nishimura 1990        |  |  |
| adur                            | LVEDP                                                                |       | adur<br>> Adur predicts LVEDP<br>>15 mmHg                                                                     | 85                 | 79                 | Rossvold 1993         |  |  |
| adur                            | LVEDP                                                                |       | adur<br>> Adur<br>+ 20 ms predicts LVEDP<br>>12 mmHg                                                          | 71                 | 95                 | Appleton 1993         |  |  |
| Adur/adur                       | LVEDP                                                                | −0.70 | Adur/adur<br>≤0.9 predicts LVEDP<br>≥20 mmHg                                                                  | 90                 | 90                 | Cecconi 1996          |  |  |
| PVS/(PVS<br>+<br>PVD)           | LAP                                                                  | −0.88 | PVS/(PVS<br>+ PVD) <55% indicates<br>LAP ≥15 mmHg                                                             | 91                 | 87                 | Kuecherer 1990        |  |  |
| PVDDT                           | LAP                                                                  | −0.92 | DT of PVD<br><175 ms predicts<br>LAP >17 mmHg                                                                 | 100                | 94                 | Kinnaird 2001         |  |  |
| Tissue Doppler                  |                                                                      |       |                                                                                                               |                    |                    |                       |  |  |
| E/E′                            | PAWP                                                                 | 0.87  | PAWP = 1.24 (E/E′) + 1.9 mmHg                                                                                 |                    |                    | Nagueh 1997           |  |  |
| E/E′                            | Mean LVDP                                                            | 0.64  | E/E′ <8 predicts normal LVDP E/E′ >15<br>predicts mean LVDP >15 mmHg                                          |                    | 86                 | Ommen 2000            |  |  |
| E/E′                            | LVDP (pre-a<br>wave)                                                 | 0.74  | E/E′ ≥9 predicts elevated LVDP<br>(>12 mmHg)                                                                  | 81                 | 80                 | Kim 2000              |  |  |
| E/E′                            | BNP levels<br>and clinical<br>outcome<br>in HFrEF                    |       | Septal E/E′ correlated with BNP levels<br>(r = 0.38) and adverse cardiac<br>events (HR: 1.91; CI: 1.25–2.96). |                    |                    | Tang 2011             |  |  |
| E/E′                            | Direct LA<br>pressure in<br>HFrEF                                    | 0.46  | Septal E/E′ ≥15 was the most<br>accurate predictor of LAP ≥15<br>mmHg with ROC area >0.9                      | 84                 | 91                 | Ritzema 2011          |  |  |
| E/E′                            | PAWP in<br>HRrEF                                                     | 0.61  | Average E/E′ >15 predicted PAWP<br>>15 mmHg with ROC area 0.92.<br>Accuracy higher without LBBB or<br>CRT     | 89                 | 91                 | Nagueh 2011           |  |  |

*Adur,* Time duration of transmitral *A*-velocity; *adur,* time duration of pulmonary venous *a*-velocity; *BNP,* B-type natriuretic peptide; *CI,* confidence interval; *CRT,* cardiac resynchronization therapy; *DT,* deceleration time (of *E*-wave); *E,* early diastolic transmitral flow velocity; *E*′, early diastolic myocardial Doppler tissue velocity; *E/A,* ratio of early to late diastolic filling velocity; *HFrEF,* heart failure with reduced ejection fraction; *HR,* hazard ratio; *LAP,* left atrial pressure; *LBBB,* left bundle branch block; *LVDP,* LV diastolic pressure; *LVEDP,* LV end-diastolic pressure; *PAWP,* pulmonary artery wedge pressure; *PVD,* diastolic pulmonary vein velocity; *PVS,* systolic pulmonary vein velocity; *PVDDT,* deceleration time of PVD; *PWP,* pulmonary wedge pressure; *ROC,* receiver-operator curve. Data from Appleton et al: *J Am Coll Cardiol* 22:1972–1982, 1993; Channer et al: *Lancet* 1:1005–1007, 1986; Giannuzzi et al: *J Am Coll* 

*Cardiol* 23:1630–1637, 1994; Cecconi et al: *J Am Soc Echocardiogr* 9:241–250, 1996; Nishimura et al: *J Am Coll Cardiol* 28:1226–1233, 1996; Schwammenthal et al: *Am J Cardiol* 86:169–174, 2000; Nishimura et al: *Circulation* 8:1488–1497, 1990; Rossvold et al: *J Am Coll Cardiol* 21:1687, 1993; Kuecherer et al: *Circulation* 82:1127–1139, 1990; Kinnaird et al: *J Am Coll Cardiol* 37:2025–2030, 2001; Nagueh et al: *J Am Coll Cardiol* 15:1527–1533, 1997; Ommen et al: *Circulation* 102:1788–1794, 2000; Kim et al: *J Am Soc Echocardiogr* 13:980–985, 2000; Tang et al: *J Card Fail* 17(2):128–134, 2011; Ritzema et al: *JACC Cardiovasc Imaging* 4(9):927–934, 2011; Nagueh et al: *Circ Cardiovasc Imaging* 4(3):220–227, 2011. For E/E′ also see: Sharifov OF, Schiros CG, Aban I, et al: Diagnostic accuracy of tissue Doppler index e/e′ for evaluating left ventricular filling pressure and diastolic dysfunction/heart failure with preserved ejection fraction: a systematic review and meta-analysis, *J Am Heart Assoc* 5(1):e002530, 2016.

TABLE B.6 Selected Studies on the Diagnostic Accuracy of Exercise Echocardiography Compared With Coronary Angiography[\\*](#page-5-0)

| First Author<br>and Year | n   | Exercise Type | Sensitivity (%) | Specificity (%) | Accuracy (%) |
|--------------------------|-----|---------------|-----------------|-----------------|--------------|
| Armstrong 1987           | 123 | TME           | 87              | 86              | 88           |
| Ryan 1988                | 64  | TME           | 78              | 100             | 86           |
| Marwick 1992             | 179 | TME           | 84              | 86              | 85           |
| Quinones 1992            | 112 | TME           | 74              | 88              | 78           |
| Ryan 1993                | 309 | UBE           | 91              | 78*             | 87           |
| Marwick 1995             | 161 | TME/UBE       | 80              | 81              | 81           |
| Luotolahti 1996          | 118 | UBE           | 94              | 72              | 92           |
| Roger 1997               | 340 | TME           | 78              | 41              | 69           |

<span id="page-5-0"></span><sup>\*</sup>In all studies, significant coronary artery disease was defined as a 50% stenosis in an epicardial vessel.

*TME,* Treadmill exercise treadmill testing; *UBE,* upright bicycle exercise.

Data from Armstrong et al: *J Am Coll Cardiol* 10:531–538, 1987; Ryan et al: *J Am Coll Cardiol* 11:993–999, 1988; Marwick et al: *J Am Coll Cardiol* 19:74–81, 1992; Quinones et al: *Circulation* 85:1026–1031, 1992; Ryan: *J Am Soc Echocardiogr* 6: 186–197, 1993; Marwick et al: *J Am Coll Cardiol* 26:335–341, 1995; Luotolahti et al: *Ann Med* 28:73–77, 1996; Roger et al: *Circulation* 95: 405–410, 1997. See also Ashley EA, Myers J, Froelicher V: Exercise testing in clinical medicine, *Lancet* 356(9241):1592–1597, 2000; and Dowsley T, Al-Mallah M, Ananthasubramaniam K, et al: The role of noninvasive imaging in coronary artery disease detection, prognosis, and clinical decision making. *Can J Cardiol* 29(3):285–296, 2013.

TABLE B.7 Selected Studies on Diagnostic Accuracy of Dobutamine Stress Echocardiography Compared With Coronary Angiography

| First Author and   |     |            | % Stenosis Considered |                 |                 |
|--------------------|-----|------------|-----------------------|-----------------|-----------------|
| Year               | n   | % With CAD | Significant           | Sensitivity (%) | Specificity (%) |
| Cohen and 1991     | 70  | 27         | 70                    | 86              | 95              |
| Sawada and 1991    | 103 | 44         | 50                    | 89              | 85              |
| Mazeika and 1992   | 50  | 26         | 70                    | 78              | 93              |
| Martin and 1992    | 40  | 35         | 50                    | 76              | 60              |
| Segar and 1992     | 85  | —          | 50                    | 95              | 82              |
| Marcovitz and 1992 | 141 | 21         | 50                    | 96              | 66              |
| Marwick and 1993   | 217 | 65         | 50                    | 72              | 83              |
| Lewis 1999*        | 92  | 27         | 50                    | 50              | 81              |
| Eroglu 2006†       | 36  | 78         | 50                    | 93              | 75              |
| Nedelijkovic 2006  | 166 | 42         | 50                    | 96              | 92              |

<span id="page-5-1"></span><sup>\*</sup>All subjects in this study were women.

<span id="page-5-2"></span>Sensitivity and specificity were the same for 2D and real-time 3D imaging, but acquisition time was shorter with 3D imaging. *CAD,* Coronary heart disease.

Data from Cohen et al: *Am J Cardiol* 67:1311–1318, 1991; Sawada et al: *Circulation* 83:1602–1614, 1991; Mazeika et al: *J Am Coll Cardiol* 19:1203–1211, 1992; Martin et al: *Ann Intern Med* 116:190–196, 1992; Segar et al: *J Am Coll Cardiol* 19:1197–1202, 1992; Marcovitz et al: *Am J Cardiol* 69:1269–1273, 1992; Marwick et al: *J Am Coll Cardiol* 22:159–167, 1993; Lewis et al: *J Am Coll Cardiol* 33(6):1462–1468, 1999; Eroglu et al: *Eur Heart J* 27(14):1719–1724, 2006; Nedelijkovic et al: *Cardiovasc Ultrasound* 4:22, 2006. See also: Heijenbrok-Kal MH, Fleischmann KE, Hunink MG. Stress echocardiography, stress single-photon-emission computed tomography and electron beam computed tomography for the assessment of coronary artery disease: a meta-analysis of diagnostic performance. Am Heart J. 2007 Sep;154(3):415-23.

| Table B.8<br>Selected Studies on the Prognostic Value of Exercise Stress Echocardiography |                              |               |                                 |                                                  |                             |                                                                                                                                                                                                                                                                                                                                         |
|-------------------------------------------------------------------------------------------|------------------------------|---------------|---------------------------------|--------------------------------------------------|-----------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| First Author<br>and Year                                                                  | n                            | Female<br>(%) | Study<br>Group                  | Outcomes<br>(Event Rate)                         | Median<br>Follow-Up<br>(yr) | Multivariate Predictors of Outcome*                                                                                                                                                                                                                                                                                                     |
| Arruda-Olson<br>2002                                                                      | 5798                         | 43            | CAD                             | Cardiac death/<br>MI (4.4%)                      | 3.2                         | •<br>Exercise workload (METs)<br>•<br>Exercise WMSI                                                                                                                                                                                                                                                                                     |
| Marwick<br>2001                                                                           | 5375                         | 37            | CAD                             | All deaths<br>(12%)                              | 5.5                         | •<br>Duke treadmill score<br>•<br>Resting wall motion (scar)<br>•<br>Exercise wall motion (ischemia)                                                                                                                                                                                                                                    |
| Elhendy<br>2002                                                                           | 4347                         | 49            | CAD                             | Cardiac death/<br>MI (3.1%)                      | 3.0                         | •<br>Resting EF<br>•<br>Exercise wall motion (ischemia)                                                                                                                                                                                                                                                                                 |
| Bergeron<br>2004                                                                          | 3260                         | 55            | Chest pain<br>and/or<br>dyspnea | Cardiac death/<br>MI (3.3%)                      | 3.1                         | •<br>Previous MI<br>•<br>Ejection fraction<br>•<br>Rest to exercise ΔWMSI                                                                                                                                                                                                                                                               |
| Shaw 2005†                                                                                | 4234<br>women<br>6898<br>men |               |                                 | Cardiac death<br>2.4% in<br>women<br>3.3% in men | 5                           | •<br>LV function and extent of ischemia<br>•<br>Risk-adjusted 5-year survival was<br>99.4, 97.6, and 95% for exercising<br>women with no, single-vessel, and<br>multivessel ischemia (P < 0.0001).<br>•<br>Exercising men had a 2.0-fold higher<br>risk at every level of worsening<br>ischemia (P < 0.0001).                           |
| Peteiro 2010                                                                              | 2947                         | 395           | CAD                             | Mortality<br>(5.6%),<br>MACE<br>(12.8%)          | 1.9 ± 1.6                   | •<br>Peak exercise WMSI predicted<br>MACE (HR 2.19, 95% CI 1.30-3.69,<br>P = 0.003) and mortality (HR 1.58,<br>95% CI 1.07-2.35, P = 0.02).                                                                                                                                                                                             |
| Arruda<br>2001a                                                                           | 2632                         | 44            | CAD age<br>≥65 yr               | Cardiac death/<br>MI (5.6%)                      | 2.9                         | •<br>Exercise workload<br>•<br>Exercise ΔEF<br>•<br>Rest to exercise ΔESV                                                                                                                                                                                                                                                               |
| Arruda<br>2001b                                                                           | 718                          | 18            | Previous<br>CABG                | Cardiac death/<br>MI (10.6%)                     | 2.9                         | •<br>Exercise workload<br>•<br>Exercise ΔEF                                                                                                                                                                                                                                                                                             |
| Elhendy<br>2001                                                                           | 563                          | 40            | Diabetes<br>and CAD             | Cardiac death/<br>MI (8.9%)                      | 3.0                         | •<br>Exercise workload<br>•<br>Resting EF<br>•<br>Extent of ischemia                                                                                                                                                                                                                                                                    |
| Elhendy<br>2003                                                                           | 483                          | 42            | CAD and<br>LVH on<br>ECG        | Cardiac death/<br>MI (12.4%)                     | 3.0                         | •<br>Exercise workload<br>•<br>Resting WMSI<br>•<br>Rest to exercise ΔEF                                                                                                                                                                                                                                                                |
| McCully<br>1998                                                                           | 1325                         | 52            | Normal<br>exercise<br>echo      | Overall and<br>cardiac<br>event-free<br>survival | 1.9                         | •<br>Overall survival of study group<br>significantly better than an age- and<br>sex-matched group obtained from<br>life tables (P < 0.0001).<br>•<br>Cardiac event-free survival rates at<br>1, 2, and 3 years were 99.2%,<br>97.8%, and 97.4%, respectively.<br>•<br>The cardiac event rate per person<br>year of follow-up was 0.9%. |
| Bouzas<br>Mosquera<br>2009                                                                | 4004                         | 41            | Normal<br>ECG<br>stress         | Death (7.8%),<br>MACE<br>(4.6%)                  | 4.5 ± 3.4                   | •<br>Change in WMSI from rest to<br>exercise predicted mortality (HR:<br>2.73, CI 1.40 to 5.32, P = 0.003) and<br>MACE (HR: 3.59, CI: 1.42 to 9.07, P<br>= 0.007).                                                                                                                                                                      |

<span id="page-6-0"></span><sup>\*</sup>In addition to clinical factors including male sex, age, diabetes, hypertension, smoking, and previous CABG. Included both treadmill and dobutamine stress echo.

<span id="page-6-1"></span>*Δ,* Change; *CABG,* coronary artery bypass graft; *CAD,* suspected or known coronary artery disease, *CI,* 95% confidence interval; *ECG,* electrocardiogram; *EF,* ejection fraction; *ESV,* end-systolic volume; *LVH,* LV hypertrophy; *MACE,* major adverse cardiac events; *METs,* metabolic equivalents; *MI,* myocardial infarction; *WMSI,* wall motion score index.

Data from Arruda et al: *J Am Coll Cardiol* 37:1036–1041, 2001a; Arruda et al: Am J Cardiol 87:1069–1073, 2001b; Arruda-Olson et al: *J Am Coll Cardiol* 39:625–631, 2002; Bergeron et al: *J Am Coll Cardiol* 43:2242–2246, 2004; Bouzas-Mosquera: *J Am Coll Cardiol* 53(21):1981– 1990; 2009; Elhendy et al: *J Am Coll Cardiol* 20:1623–1629, 2002; Elhendy et al: *J Am Coll Cardiol* 37:1551–1557, 2001; Elhendy et al: *J Am Coll Cardiol* 41:129–135, 2003; Marwick et al: *Circulation* 103:2566-2571, 2001; McCully et al: *J Am Coll Cardiol* 31(1):144–-149, 1998; Peteiro et al: *Eur Heart J* 31(2):187–195, 2010; Shaw et al: *Eur Heart J* 26(5):447–456, 2005.

| Table B.9<br>Selected Studies on the Prognostic Value of Pharmacologic Stress Echocardiography |      |               |                             |                                                                   |                             |                                                                                                                                                           |
|------------------------------------------------------------------------------------------------|------|---------------|-----------------------------|-------------------------------------------------------------------|-----------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------|
| First Author<br>and Year                                                                       | n    | Female<br>(%) | Study<br>Group              | Outcomes (Event<br>Rate)                                          | Median<br>Follow-Up<br>(yr) | Multivariate<br>Predictors of<br>Outcome*                                                                                                                 |
| Biagini 2005a                                                                                  | 3381 | 33            | CAD                         | Cardiac death, MI<br>(30%)                                        | 7 ± 3.4                     | •<br>Resting WMA<br>•<br>Ischemia                                                                                                                         |
| Marwick 2001                                                                                   | 3156 | 43            | CAD                         | Cardiac death (8%)                                                | 3.8 ± 1.9                   | •<br>Resting WMA<br>•<br>Ischemia                                                                                                                         |
| Chaowalit<br>2006                                                                              | 2349 | 43            | Diabetes                    | Death, MI, late<br>coronary<br>revascularization<br>(57%)         | 5.4 ± 2.2                   | •<br>Extent of ischemia<br>•<br>Ventricular<br>function<br>•<br>Failure to reach<br>target heart rate                                                     |
| Poldermans<br>1999                                                                             | 1659 | 29            | DSE for<br>suspected<br>CAD | Cardiac death (6.5%),<br>MI (7.7%),<br>revascularization<br>(12%0 | 3.0                         | •<br>Stress-induced<br>ischemia (hazard<br>ratio: 3.3; 95% CI:<br>2.4 to 4.4)<br>•<br>Extensive rest<br>WMA (hazard<br>ratio: 1.9; 95% CI:<br>1.3 to 2.6) |
| Biagini 2005b                                                                                  | 1434 | 33            | CAD ≥65 yr                  | Cardiac death/MI<br>(40%)                                         | 6.5                         | •<br>Resting WMA<br>•<br>Ischemia                                                                                                                         |
| Chuah 1998                                                                                     | 860  | 44            | CAD                         | Cardiac death/MI<br>(10%)                                         | 2 ± 0.8                     | •<br>Stress WMA<br>•<br>Rest to exercise<br>ΔESV                                                                                                          |

<span id="page-7-0"></span>\*In addition to clinical factors including male sex, age, diabetes, smoking, history of heart failure, and previous coronary artery bypass graft. *CAD,* Known or suspected coronary artery disease; *CI,* confidence interval; *DSE,* dobutamine stress echocardiography; *ΔESV,* change in end-systolic volume; *MI,* myocardial infarction; *WMA,* wall motion abnormalities.

From Biagini et al: *J Am Coll Cardiol* 45:93–97, 2005a; Marwick et al: *J Am Coll Cardiol* 37:754–760, 2001; Chaowalit et al: *J Am Coll Cardiol* 47:1029–1036, 2006; Biagini et al: *Gerontol A Biol Sci Med Sci* 60:1333–1338, 2005b; Chuah et al: *Circulation* 97:1474–1480, 1998; Poldermans et al: *Circulation* 99:757–762, 1999.

| Table B.10<br>Test Performance Characteristics for Echocardiographic Findings in Tamponade |                 |                 |  |  |  |  |
|--------------------------------------------------------------------------------------------|-----------------|-----------------|--|--|--|--|
| Characteristic                                                                             | Sensitivity (%) | Specificity (%) |  |  |  |  |
| Any collapse                                                                               | 90              | 65              |  |  |  |  |
| RA collapse                                                                                | 68              | 66              |  |  |  |  |
| RV collapse                                                                                | 60              | 90              |  |  |  |  |
| RA + RV collapse                                                                           | 45              | 92              |  |  |  |  |
| Abnormal venous flow*                                                                      | 75              | 91              |  |  |  |  |
| Abnormal venous flow + 1 collapse                                                          | 67              | 91              |  |  |  |  |
| Abnormal venous flow + 2 collapses                                                         | 37              | 98              |  |  |  |  |

<span id="page-7-1"></span><sup>\*</sup>Abnormal venous (hepatic vein or superior vena cava) flow defined as: marked systolic over diastolic component, expiratory accentuation of this difference, and expiratory reversal of diastolic flow.

From Merce J, Sagrista-Sauleda J, Permanyer-Miralda G, et al: Correlation between clinical and Doppler echocardiographic findings in patients with moderate and large pericardial effusion: implications for the diagnosis of cardiac tamponade, *Am Heart J* 138(4):759–764, 1999.

| TABLE B.11 | Test Performance Characteristics for Five Principal Echocardiographic Findings in |
|------------|-----------------------------------------------------------------------------------|
|            | Constrictive Pericarditis                                                         |

| Variable*                                 | Sensitivity (%) | Specificity (%) | Positive Predictive<br>Value (%) | Negative Predictive<br>Value (%) |  |
|-------------------------------------------|-----------------|-----------------|----------------------------------|----------------------------------|--|
| Individual Variables                      |                 |                 |                                  |                                  |  |
| #1 ventricular septal shift               | 93              | 69              | 92                               | 74                               |  |
| #2 change in mitral E velocity<br>≥14.6%† | 84              | 73              | 92                               | 55                               |  |
| #3 medial e′ velocity ≥9 cm/s             | 83              | 81              | 94                               | 57                               |  |
| #4 medial e′/lateral e′ ≥0.91             | 75              | 85              | 95                               | 50                               |  |
| #5 HV ratio in expiration ≥0.79           | 76              | 88              | 96                               | 49                               |  |
| Combinations Among #s 1, 3, and 5‡        |                 |                 |                                  |                                  |  |
| #1 (with or without #s 3 and/or 5)        | 93              | 69              | 92                               | 74                               |  |
| #1 and #3 (with or without #5)            | 80              | 92              | 97                               | 56                               |  |
| #1 with #s 3 and/or 5                     | 87              | 91              | 97                               | 65                               |  |
| #1 with both #s 3 and 5                   | 64              | 97              | 99                               | 42                               |  |

<span id="page-8-0"></span><sup>\*</sup>Cutpoints for continuous variables were selected from receiver-operator curve analysis.

TABLE B.12 Selected Studies Validating Doppler Pressure Gradients in Valvular Stenosis (In Vivo Simultaneous Data)

| First Author  |     |                                               |                               |                |            |
|---------------|-----|-----------------------------------------------|-------------------------------|----------------|------------|
| and Year      | n   | Study Group/Model                             | r                             | Range (mmHg)   | SEE (mmHg) |
| Callahan 1985 | 120 | Supravalvular constriction<br>(canines)       | 0.99 (ΔPmax)<br>0.98 (ΔPmean) | 7179<br>N/A    | 5.2<br>4.3 |
| Smith 1985    | 88  | Supravalvular constriction<br>(canines)       | 0.98 (ΔPmax)<br>0.98 (ΔPmean) | 5–166<br>5–116 | 5.3<br>3.3 |
| Currie 1985   | 100 | Adults with valvular aortic<br>stenosis       | 0.92 (ΔPmax)<br>0.92 (ΔPmean) | 2–180<br>0–112 | 15<br>10   |
| Smith 1986    | 33  | Adults with valvular aortic<br>stenosis       | 0.85 (ΔPmax)                  | 27–138         | N/A        |
| Simpson 1985  | 24  | Adults with valvular aortic<br>stenosis       | 0.98 (ΔPmax)                  | 0–120          | N/A        |
| Burwash 1993  | 98  | Chronic valvular aortic<br>stenosis (canines) | 0.95 (ΔPmax)<br>0.91 (ΔPmean) | 10–128<br>5–77 | 8.4<br>5.3 |

*N/A,* Not available; *ΔP,* pressure gradient; *SEE,* standard error of the estimate.

Data from Callahan et al: *Am J Cardiol* 56:989–993, 1985; Smith et al: *J Am Coll Cardiol* 6:1306–1314, 1985; Currie et al: *Circulation* 71:1162–1169, 1985; Smith et al: *Am Heart J* 111:245–252, 1986; Simpson et al: *Br Heart J* 53:636–639, 1985; Burwash et al: *Am J Physiol* 265:H734–H1743, 1993.

<span id="page-8-1"></span>Based on [(expiratory velocity − inspiratory velocity)/inspiratory velocity × 100]; value will be slightly lower if the currently recommended [(expiratory velocity − inspiratory velocity)/expiratory velocity × 100] is used.

<span id="page-8-2"></span>Limited to echocardiographic findings (in **bold**) that were independently associated with the diagnosis of constrictive pericarditis.

*HV,* Hepatic vein (HV ratio = diastolic reversal velocity/forward velocity). From Welch TD, Ling LH, Espinosa RE, et al: Echocardiographic diagnosis of constrictive pericarditis: Mayo Clinic criteria, *Circ Cardiovasc Imaging* 7(3):526–534, 2014.

| TABLE B.13                   | Selected Studies of Aortic Valve Area Determination |     |                                                            |              |                    |                                    |  |
|------------------------------|-----------------------------------------------------|-----|------------------------------------------------------------|--------------|--------------------|------------------------------------|--|
| First Author<br>and Year     | Comparison                                          | n   | Study Group                                                | r*           | Range (cm2<br>)    | SEE* (cm2<br>)                     |  |
| Hakki 1981                   | Simplified vs. original<br>Gorlin formula           | 60  | Aortic<br>stenosis                                         | 0.96         | 0.2–2.0            | 0.10                               |  |
| Zoghbi 1986                  | Cont eq vs. Gorlin                                  | 39  | Aortic<br>stenosis                                         | 0.95         | 0.4–2.0            | 0.15                               |  |
| Otto 1986                    | Cont eq vs. Gorlin                                  | 48  | Aortic<br>stenosis                                         | 0.71         | 0.2–3.7            | 0.32                               |  |
| Oh 1988                      | Cont eq vs. Gorlin                                  | 100 | Aortic<br>stenosis                                         | 0.83         | 0.2–1.8            | 0.19                               |  |
| Danielson<br>1989            | Cont eq vs. Gorlin                                  | 100 | Aortic<br>stenosis                                         | 0.96         | 0.4–2.0            | —                                  |  |
| Cannon 1985                  | Gorlin vs. videotape of<br>valve opening            | 42  | Porcine valves<br>in pulsatile                             | 0.87         | 0.6–2.5            | 0.28                               |  |
|                              | New formula vs. actual<br>orifice area              | 42  | flow model<br>Porcine valves<br>in pulsatile<br>flow model | 0.98         | 0.6–2.5            | 0.11                               |  |
| Segal 1987                   | Cont eq vs. actual<br>valve area                    |     | In vitro<br>pulsatile                                      | 0.99         | 0.05–0.5           | 0.016                              |  |
|                              | Gorlin formula vs.<br>actual valve area             |     | flow with<br>orifice<br>plates                             | 0.87         |                    | 0.047                              |  |
| Cannon 1988                  | Gorlin vs. known valve<br>area                      | 135 | Prosthetic<br>aortic<br>valves                             | 0.39         | 0.6–2.3            | —                                  |  |
| Nishimura<br>1988            | Cont eq vs. Gorlin                                  | 55  | Pre-BAV<br>Post-BAV                                        | 0.72<br>0.61 | 0.2–0.9<br>0.5–1.3 | 0.10<br>0.17                       |  |
| Desnoyers<br>1988            | Cont eq vs. Gorlin                                  | 42  | Pre-BAV                                                    | 0.74         | 0.3–1.3            | —                                  |  |
| Tribouilloy<br>1994          | TEE vs. cont eqTEE<br>vs. Gorlin                    | 54  | Aortic<br>stenosis                                         | 0.96<br>0.90 | 0.3–2.0            | 0.110.12                           |  |
| Kim 1997                     | TEE vs. Gorlin                                      | 81  | Aortic<br>stenosis                                         | 0.89         | 0.4–2.0            | 0.04                               |  |
| Bland Altman Mean Difference |                                                     |     |                                                            |              |                    |                                    |  |
| Goland 2007                  | 3D TEE AVA vs. 2D<br>TTE AVA                        | 33  | Aortic<br>stenosis                                         | 0.99         | 0.45–1.98          | 0.00 (−0.15 to 0.15) cm2           |  |
|                              | 3D TEE AVA vs. Gorlin<br>15<br>AVA                  |     |                                                            | 0.86         | 0.4–1.4            | 0.01 (−0.20 to 0.22) cm2           |  |
| De la Morena<br>2009         | 3D TEE AVA vs. TTE<br>2D AVA                        | 59  | Aortic<br>stenosis                                         | 0.72†        | 0.3–1.3            | 4.04 (0.37–0.45) cm2               |  |
| Furukawa<br>2012             | TEE 3D AVA vs. TEE<br>2D AVA                        | 25  | Aortic<br>stenosis                                         | 0.95         | 0.4–1.1            | −0.14 (range −0.41 to<br>0.12) cm2 |  |

<span id="page-9-0"></span><sup>\*</sup>If not stated in the publication, statistics were calculated from the raw data provided in tables. A blank indicates that data for this calculation were not available.

<span id="page-9-1"></span>Interclass correlation coefficient.

*AVA,* Aortic valve area *BAV,* balloon aortic valvuloplasty; *Cont eq,* continuity equation; *Gorlin,* Gorlin formula valve area; *SEE,* standard error of the estimate; *TEE,* planimetered 2D valve area on TEE; *3D AVA,* planimetry of aortic valve area on 3D imaging. Data from Hakki et al: *Circulation* 63:1050–1055, 1981; Zoghbi et al: *Circulation* 73:452–459, 1986; Otto et al: *J Am Coll Cardiol* 7:509–517, 1986; Oh et al: *J Am Coll Cardiol* 11:1227–1234, 1988; Danielson et al: *Am J Cardiol* 63:1107–1111, 1989; Cannon et al: *Circulation* 71:1170–1178, 1985; Segal et al: *J Am Coll Cardiol* 9:1294–1305, 1987; Cannon et al: *Am J Cardiol* 62:113–116, 1988; Nishimura et al: *Circulation* 78:791–799, 1988; Desnoyers et al: *Am J Cardiol* 62:1078–1084, 1988; Tribouilloy et al: *Am Heart J* 128:526–532, 1994; Kim et al: *Am J Cardiol* 79:436–441, 1997; Goland et al: *Heart* 93(7):801–807, 2007; de la Morena et al: *Eur J Echocardiogr* 11(1):9–13, 2010; Furukawa et al: *J Cardiol* 59(3):337–343, 2012.

| First Author       |                                                           |                          |                                                                      |                              |                        |                              |
|--------------------|-----------------------------------------------------------|--------------------------|----------------------------------------------------------------------|------------------------------|------------------------|------------------------------|
| and Year           | Comparison                                                | n                        | Study Group                                                          | r                            | Range (cm2<br>)        | SEE (cm2<br>)                |
| Gorlin 1951        | MVA by Gorlin formula<br>vs. direct autopsy or<br>surgery | 11                       | MS                                                                   | 0.89                         | 0.5–1.5                | 0.15                         |
| Libanoff 1968      | T½ at rest vs. exercise                                   | 20                       | Mitral valve disease                                                 | 0.98                         | 20–340 ms              | 21 ms                        |
| Henry 1975         | 2D echo vs. direct<br>measurement at<br>surgery           | 20                       | MS patients<br>undergoing surgery                                    | 0.92                         | 0.5–3.5                | —                            |
| Holen 1977         | MVA by Doppler vs.<br>Gorlin                              | 10                       | MS                                                                   | 0.98                         | 0.6–.4                 | 0.18                         |
| Hatle 1979         | T½ vs. Gorlin MVA                                         | 32                       | MS                                                                   | 0.74                         | 0.4–3.5                | —                            |
| Smith 1986         | 2D echo vs. Gorlin<br>T½ MVA vs. Gorlin                   | 37<br>35<br>(37)<br>(35) | MS alone<br>Prior commissurotomy<br>MS alone<br>Prior commissurotomy | 0.83<br>0.58<br>0.85<br>0.90 | 0.4–2.3                | 0.26<br>0.28<br>0.22<br>0.14 |
| Come 1988          | T½ MVA vs. Gorlin                                         | 37                       | Pre-MBC<br>Post-MBC                                                  | 0.51<br>0.47                 | 0.6–1.3<br>1.2–3.8     | —<br>—                       |
|                    | Gorlin vs. Gorlin                                         |                          | Repeat catheter                                                      | 0.74                         | 0.4–1.4                | —                            |
| Thomas 1988        | Predicted vs. actual T½                                   | 18                       | Pre-MBC<br>Post-MBC                                                  |                              | 0.93–0.96<br>0.52–0.66 |                              |
| Chen 1989          | T½ MVA vs. Gorlin                                         | 18                       | Pre-MBC<br>Immediately post<br>MBC                                   | 0.81<br>0.84                 | 0.4–1.2<br>1.3–2.6     | 0.11<br>0.20                 |
|                    |                                                           |                          | 24–48 hr post-MBC                                                    | 0.72                         | 1.3–2.6                | 0.49                         |
| Faletra 1996       | 2D echo vs. direct<br>measurement                         | 30                       | MS undergoing<br>surgical mitral valve<br>replacement                | 0.95                         | 0.6–2.0                | 0.06                         |
|                    | T½ vs. direct<br>measurement                              | 30                       |                                                                      | 0.80                         |                        | 0.09                         |
|                    | Cont eq vs. direct                                        | 30                       |                                                                      | 0.87                         |                        | 0.09                         |
|                    | measurement<br>Flow area vs. direct<br>measurement        | 30                       |                                                                      | 0.54                         |                        | 0.10                         |
|                    | Bland Altman Mean Difference                              |                          |                                                                      |                              |                        |                              |
| Dreyfus 2011       | 3D MVA on TEE vs. 2D<br>MVA on TTE                        | 80                       | MS                                                                   | 0.79                         | 0.45–2.20              | 0.0004 ± 0.22 cm2            |
| Schlosshan<br>2011 | 3D MVA on TEE vs. 2D<br>MVA                               | 43                       | MS                                                                   | 0.87                         | 0.5–2.5                | −0.16 ± 0.22 cm2             |
|                    | 3D MVA on TEE vs. T½<br>MVA                               |                          |                                                                      | 0.73                         |                        | −0.23 ± 0.28 cm2             |
|                    | 3D MVA on TEE vs.<br>Cont. eq MVA                         |                          |                                                                      | 0.83                         |                        | 0.05 ± 0.22 cm2              |

*Cont eq,* Continuity equation; *Gorlin,* Gorlin formula valve area; *MBC,* mitral balloon commissurotomy; *MS,* mitral stenosis; *MVA,* mitral valve area; *SEE,* standard error of the estimate; *T½,* pressure half-time.

Data from Gorlin et al*: Am Heart J* 41:1–29, 1951; Libanoff et al: *Circulation* 38:144–150, 1968; Henry et al: *Circulation* 51:827–831, 1975; Holen et al: *Acta Med Scand* 201:83–88, 1977; Hatle et al: *Circulation* 60:1096–1104, 1979; Smith et al: *Circulation* 73:100–107, 1986; Come et al: *Am J Cardiol* 61:817–825, 1988; Thomas et al: *Circulation* 78:980–993, 1988; Chen et al: *J Am Coll Cardiol* 13:1309–1313, 1989; Faletra et al: *J Am Coll Cardiol* 28:1190–1197, 1996; Dreyfus J et al: *Eur J Echocardiogr* 12(10):750–755, 2011; Schlosshan D et al: *JACC Cardiovasc Imaging* 4(6):580–588, 2011.

| TABLE B.15<br>Selected Studies Validating Quantitative Evaluation of Regurgitant Severity Using<br>Doppler Echocardiography |                                                |                                               |                                         |                          |               |  |  |
|-----------------------------------------------------------------------------------------------------------------------------|------------------------------------------------|-----------------------------------------------|-----------------------------------------|--------------------------|---------------|--|--|
| First Author and<br>Year                                                                                                    | Method                                         | Standard of<br>Reference                      | n                                       | r                        | SEE           |  |  |
| Color Jet Area                                                                                                              |                                                |                                               |                                         |                          |               |  |  |
| Spain 1989                                                                                                                  | Color jet area                                 | Angio LV, TD-CO                               | 15 patients with<br>MR                  | 0.62 (RF)                | —             |  |  |
| Tribouilloy 1992                                                                                                            | Regurgitant jet<br>width at origin             | Angio LV, TD-CO                               | 31 patients with<br>MR                  | 0.85 (RSV)               | —             |  |  |
| Enriquez-Sarano<br>1993                                                                                                     | Color jet area                                 | Doppler SV at<br>two sites                    | 80 patients with<br>MR                  | 0.69 (RF)                | 4.4 cm2       |  |  |
| Vena Contracta                                                                                                              |                                                |                                               |                                         |                          |               |  |  |
| Tribouilloy 2000                                                                                                            | Vena contracta                                 | Doppler EROA                                  | 79 patients with                        | 0.89 (EROA)              | 0.08 cm2      |  |  |
|                                                                                                                             | width                                          | and RV                                        | AR                                      | 0.90 (RV)                | 18 mL         |  |  |
| Hall 1997                                                                                                                   | Vena contracta                                 | Doppler EROA                                  | 80 patients with                        | 0.86 (EROA)              | 0.15 cm2      |  |  |
|                                                                                                                             | width                                          | and RV                                        | MR                                      | 0.85 (RV)                | 20 mL         |  |  |
| PISA                                                                                                                        |                                                |                                               |                                         |                          |               |  |  |
| Recusani 1991                                                                                                               | PISA<br>(hemispherical)                        | Rotometer                                     | In vitro, constant<br>flow              | 0.94–0.99 (flow<br>rate) | 1.0–1.6 L/min |  |  |
| Utsunomiya 1991                                                                                                             | PISA<br>(hemispherical)                        | Actual flow rate<br>stopwatch and<br>cylinder | In vitro, pulsatile<br>flow             | 0.99 (flow rate)         | 0.53 L/min    |  |  |
| Vandervoort<br>1993                                                                                                         | PISA                                           | Actual flow rate                              | In vitro, steady<br>flow                | 0.98–0.99 (flow<br>rate) | —             |  |  |
| Giesler 1993                                                                                                                | PISA                                           | LV angio, Fick<br>CO                          | 16 patients with<br>MR                  | 0.88 (RSV)               | 17 mL         |  |  |
| Chen 1993                                                                                                                   | PISA                                           | Doppler SV at<br>two sites                    | 46 patients with<br>MR                  | 0.94 (RSV)               | 18 mL         |  |  |
| CW Doppler                                                                                                                  |                                                |                                               |                                         |                          |               |  |  |
| Teague 1986                                                                                                                 | AR half-time                                   | Angio LV, Fick<br>CO                          | 32 patients with<br>AR                  | ~0.88 (RF)               | 11%           |  |  |
| Masuyama 1986                                                                                                               | AR half-time                                   | Angio LV, ID-CO                               | 20 patients with<br>AR                  | ~0.89 (RF)               | —             |  |  |
| Volume Flow at Two Sites                                                                                                    |                                                |                                               |                                         |                          |               |  |  |
| Ascah 1985                                                                                                                  | Transmitral vs.<br>transaortic SV              | EM-flow                                       | 30 flow rates in<br>canine model        | 0.83 (RF)                | —             |  |  |
| Kitabatake 1985                                                                                                             | Transaortic vs.<br>transpulmonic<br>SV         | Angio LV, TD-CO                               | 20 patients with<br>AR                  | 0.94 (RF)                | —             |  |  |
| Rokey 1986                                                                                                                  | Transmitral vs.<br>transaortic SV              | Angio LV, TD-CO                               | 19 patients with<br>MR and 6 with<br>AR | 0.91 (RF)                | 7%            |  |  |
| Distal Flow Reversals                                                                                                       |                                                |                                               |                                         |                          |               |  |  |
| Boughner 1975                                                                                                               | Diastolic flow<br>reversal in<br>descending Ao | Angio LV, Fick<br>CO                          | 15 patients with<br>AR                  | 0.91 (RF)                | —             |  |  |
| Touche 1985                                                                                                                 | Diastolic flow<br>reversal in<br>descending Ao | Angio LV, TD-CO                               | 30 patients with<br>AR                  | 0.92 (RF)                | 8.8%          |  |  |

| TABLE B.15 | Selected Studies Validating Quantitative Evaluation of Regurgitant Severity Using |
|------------|-----------------------------------------------------------------------------------|
|            | Doppler Echocardiography—cont'd                                                   |

| First Author and<br>Year      | Method            | Standard of<br>Reference | n                                 | r             | SEE                              |
|-------------------------------|-------------------|--------------------------|-----------------------------------|---------------|----------------------------------|
| 3D Doppler Color Flow Imaging |                   |                          |                                   |               |                                  |
| Marsan 2009                   | 3D vena contracta | CMR                      | 64 patients with<br>functional MR | 0.94          | −0.08 (−7.7 to<br>−7.6) mL/beat* |
| Zeng 2011                     | 3D vena contracta | Quantitative<br>Doppler  | 49 patients with<br>MR            | 2 = 0.86<br>r | 0.02 cm2                         |
| Perez de Isla<br>2012         | 3D vena contracta | CMR                      | 32 patients with<br>AR            | 0.88          | —                                |

<span id="page-12-0"></span><sup>\*</sup>Bland-Altman mean difference and limits of agreement.

Baumgartner H, et al: *J Am Coll Cardiol* 19:324–332, 1992.

*Angio,* Angiography; *Ao,* aorta; *AR,* aortic regurgitation; *CMR,* cardiac magnetic resonance imaging; *CO,* cardiac output; *EM-flow,* volume flow rate measured by electromagnetic flowmeter; *EROA,* effective regurgitant orifice area; *ID,* indicator dilation; *MR,* mitral regurgitation; *PISA,* proximal isovelocity surface area method; *RF,* regurgitant fraction; *RSV,* regurgitant stroke volume; *SEE,* standard error of the estimate; *SV,* stroke volume; *TD,* thermodilution.

Data from Spain et al*: J Am Coll Cardiol* 13:585–590, 1989; Tribouilloy et al: *Circulation* 85:1248–1253, 1992; Enriquez-Sarano et al: *J Am Coll Cardiol* 21:1211–1219, 1993; Tribouilloy et al: *Circulation* 102:558–564, 2000; Hall et al: *Circulation* 95: 636–642, 1997; Rescusani et al: *Circulation* 83:594–604, 1991; Utsunomiya et al: *J Am Soc Echocardiogr* 4:338–348, 1991; Vandervoort et al: *J Am Coll Cardiol* 22:535– 541, 1993; Giesler et al: Am J Cardiol 71:217–224, 1993; Chen et al: *J Am Coll Cardiol* 21:374–383, 1993; Teague et al: *J Am Coll Cardiol* 8:592–599, 1986; Masuyama et al: *Circulation* 73:460–466, 1986; Ascah et al: *Circulation* 72:377–383, 1985; Kitabatake et al: *Circulation* 72:523–529, 1985; Rokey et al: *J Am Coll Cardiol* 7:1273–1278, 1986; Bougher et al: *Circulation* 52:874–879, 1975; Touche et al: *Circulation* 72:819–824, 1985; Marsan et al: *JACC Cardiovasc Imaging* 2(11):1245–1252, 2009; Zeng et al: *Circ Cardiovasc Imaging* 4(5):506–513, 2011; Perez de Isla et al: *Int J Cardiol* 166(3):640-645, 2011.

TABLE B.16 Validation of Doppler Echo Prosthetic Mean Valve Gradients Compared With Invasive Data (Selected Series)

| First Author and<br>Year | Valve Type<br>(Position)                               | n                                            | r                            | SEE<br>(mmHg)            | Mean Difference                                               |
|--------------------------|--------------------------------------------------------|----------------------------------------------|------------------------------|--------------------------|---------------------------------------------------------------|
| Sagar 1986               | Hancock and B-S<br>(mitral)                            | 19                                           | 0.93                         | 2.5                      | —                                                             |
| Sagar 1986               | Hancock and B-S<br>(aortic)                            | 11                                           | 0.94                         | 7.4                      | —                                                             |
| Wilkins 1986             | Starr-Edwards, B-S<br>porcine (mitral)                 | 11                                           | 0.96                         | —                        | —                                                             |
| Burstow 1989             | Mixed (aortic)<br>Mixed (mitral)                       | 20<br>20                                     | 0.94<br>0.97                 | 3<br>1.2                 | —<br>—                                                        |
| Baumgartner 1990         | St. Jude<br>Hancock                                    | In vitro<br>In vitro                         | 0.98<br>0.98                 | 1.9<br>1.4               | 10 ± 3 mmHg<br>2 ± 1 mmHg                                     |
| Stewart 1991             | Bioprosthetic<br>(aortic)                              | In vitro                                     | 0.78-0.98                    | —                        | Overestimation by Doppler                                     |
| Baumgartner 1992         | St. Jude<br>Medtronic-Hall<br>Starr-Edwards<br>Hancock | In vitro<br>In vitro<br>In vitro<br>In vitro | 0.98<br>0.99<br>0.97<br>0.99 | 2.0<br>0.5<br>2.0<br>1.5 | 13 ± 8 mmHg<br>0.8 ± 0.6 mmHg<br>8 ± 4 mmHg<br>1.9 ± 1.6 mmHg |

*B-S,* Björk-Shiley tilting-disk mechanical valve; *SEE,* standard error of the estimate. From Sager KB, et al: *J Am Coll Cardiol* 7:681–687, 1986; Wilkins GT, et al: *Circulation* 74:786–795, 1986; Burstow DJ, et al: *Circulation* 80:504–514, 1989; Baumgartner H, et al: *Circulation* 82:1467–1475, 1990; Stewart SF, et al: *J Am Coll Cardiol* 18:769–779, 1991;

| Table B.17<br>Validation of Doppler Echo Prosthetic Valve Areas (Selected Series) |                                              |                                  |                                             |                      |                      |                                                                    |  |
|-----------------------------------------------------------------------------------|----------------------------------------------|----------------------------------|---------------------------------------------|----------------------|----------------------|--------------------------------------------------------------------|--|
| First Author and<br>Year                                                          | Valve Type<br>(Position)                     | n                                | Comparison                                  | r                    | SEE                  | Mean Difference                                                    |  |
| Sagar 1986                                                                        | Hancock and B-S<br>(mitral)                  | 12                               | T½ vs. Gorlin                               | 0.98                 | 0.1 cm2              | —                                                                  |  |
| Wilkins 1986                                                                      | Porcine<br>(mitral)                          | 8                                | T½ vs. Gorlin                               | 0.65                 | —                    | —                                                                  |  |
| Rothbart 1990                                                                     | Bioprosthetic<br>(aortic)                    | 22                               | Cont eq vs. Gorlin<br>at<br>catheterization | 0.93                 | —                    | —                                                                  |  |
| Chafizadeh 1991                                                                   | St. Jude<br>(aortic)                         | 67                               | Cont eq vs. actual<br>orifice area          | 0.83                 | —                    | Doppler effective orifice<br>area less than actual<br>orifice area |  |
| Baumgartner 1992                                                                  | St. Jude<br>Medtronic-Hall<br>Hancock aortic | In vitro<br>In vitro<br>In vitro | Cont eq vs. Gorlin                          | 0.99<br>0.97<br>0.93 | 0.08<br>0.10<br>0.10 | 0.4–0.6 cm2<br>0–0.25 cm2<br>0–0.25 cm2                            |  |

*B-S,* Björk-Shiley tilting-disk mechanical valve; *Cont eq,* continuity equation valve area with Doppler and 2D echo data; *Gorlin,* Gorlin formula valve area using invasive data; *SEE,* standard error of the estimate; *T <sup>1</sup> <sup>2</sup> ,* Doppler pressure half-time method. From Sager KB, et al: *J Am Coll Cardiol* 7:681–687, 1986; Wilkins GT, et al: *Circulation* 74:786–795, 1986: Rothbart R, et al: *J Am Coll Cardiol* 15:817–824, 1990; Chafizadeh ER, Zoghbi WA: *Circulation* 83:213–223, 1991; Baumgartner H, et al: *J Am Coll Cardiol* 19:324–332, 1992.

| First<br>Author   | Study Entry Criteria<br>(Standard of                           | No. of<br>Valves | Percent<br>Prosthetic<br>(%) |             | TTE         | TEE                                        |              |
|-------------------|----------------------------------------------------------------|------------------|------------------------------|-------------|-------------|--------------------------------------------|--------------|
| and Year          | Reference)                                                     |                  |                              | Sensitivity | Specificity | Sensitivity                                | Specificity  |
| Mugge<br>1989     | Definite endocarditis<br>plus surgery or<br>autopsy            | 91               | 23                           | 53/91 (58%) | —           | 82/91 (90%)                                | —            |
| Jaffe 1990        | Definite endocarditis<br>plus surgery or<br>autopsy            | 38               | 16                           | 38/44 (86%) | —           | —                                          | —            |
| Burger<br>1991    | Suspected endocarditis<br>and clinical outcome                 | 101              | —                            | 35/39 (90%) | 61/62 (98%) | —                                          | —            |
| Shively<br>1991   | Suspected endocarditis<br>and clinical outcome                 | 6                | 18                           | 7/16 (44%)  | 49/50 (98%) | 15/16 (94%)                                | 50/50 (100%) |
| Pedersen<br>1991  | Suspected endocarditis<br>and clinical outcome                 | 24               | 42                           | 5/10 (50%)  | 13/14 (93%) | 10/10 (100%)                               | 14/14 (100%) |
| Daniel<br>1993    | Prosthetic valve with<br>surgically confirmed<br>endocarditis  | 33               | 100                          | 12/33 (36%) | —           | 27/33 (82%)                                | —            |
| Sochowski<br>1993 | Suspected endocarditis<br>with initially negative<br>TTE study | 65               | 12                           | —           | —           | Negative predictive value =<br>56/65 (86%) |              |
| Shapiro<br>1994   | Suspected endocarditis                                         | 68               | —                            | 23/34 (68%) | 31/34 (91%) | 33/34 (97%)                                | 31/34 (91%)  |

Data from Mugge et al: *J Am Coll Cardiol* 14:631–638, 1989; Jaffe et al: *J Am Coll Cardiol* 15:1227–1233, 1990; Burger et al: *Angiology* 42:552–560, 1991; Shiveley et al: *J Am Coll Cardiol* 18:391–397, 1991; Pedersen et al: *Chest* 100:351–356, 1991; Daniel et al: *Am J Cardiol* 71:210-215, 1993; Sochowski, et al: *J Am Coll Cardiol* 21:216–221, 1993; Shapiro et al: *Chest* 105:377, 1994.

| First<br>Author and | Study Entry                                | No. of | Percentage<br>Prosthetic |             | TTE         | TEE          |             |
|---------------------|--------------------------------------------|--------|--------------------------|-------------|-------------|--------------|-------------|
| Year                | Criteria                                   | Valves | (%)                      | Sensitivity | Specificity | Sensitivity  | Specificity |
| Daniel 1991         | Endocarditis with<br>surgery or<br>autopsy | 137    | 25                       | 13/46 (28%) | 90/91 (99%) | 40/46 (87%)  | 87/91 (96%) |
| Jaffe 1990          | Endocarditis with<br>surgery or<br>autopsy | 7      | —                        | 5/7 (71%)   | —           | —            | —           |
| Karalis 1992        | Endocarditis with<br>surgery or<br>autopsy | 55     | 46                       | 13/24 (54%) | —           | 24/24 (100%) | —           |

| Table B.20<br>Sensitivity and Specificity of Diagnostic Tests for Intracardiac Thrombus Formation |                 |                 |  |  |  |  |  |
|---------------------------------------------------------------------------------------------------|-----------------|-----------------|--|--|--|--|--|
| Test                                                                                              | Sensitivity (%) | Specificity (%) |  |  |  |  |  |
| LA Thrombus                                                                                       |                 |                 |  |  |  |  |  |
| TTE*                                                                                              | 53–63           | 95–99           |  |  |  |  |  |
| TEE†                                                                                              | 99              | 100             |  |  |  |  |  |
| CT with contrast‡                                                                                 | 36–100          | 72–94           |  |  |  |  |  |
| Contrast angiography‡                                                                             | 70              | 88              |  |  |  |  |  |
| CMR§                                                                                              | 100             | 94              |  |  |  |  |  |
| LV Thrombus                                                                                       |                 |                 |  |  |  |  |  |
| TTEǁ                                                                                              | 92–95           | 86–88           |  |  |  |  |  |
| TEE¶                                                                                              | 40 ± 14         | 96 ± 3.6        |  |  |  |  |  |
| LV Angiography#                                                                                   | 26–31           | —               |  |  |  |  |  |
| Contrast-enhanced CMR¶                                                                            | 88–93           | 85–99           |  |  |  |  |  |

*CMR,* Cardiac magnetic resonance imaging; *CT,* computed tomographic imaging.

<span id="page-14-0"></span>\*Shrestha et al: *Am J Cardiol* 48:954–960, 1981; Chiang et al: *J Ultrasound Med* 6:525–529, 1987; Bansal et al: *Am J Cardiol* 64:243–246, 1989.

<span id="page-14-1"></span>Aschenberg et al: *J Am Coll Cardiol* 7:163–166, 1986; Olson et al: *J Am Soc Echocardiogr* 5:52–56, 1992; Hwang et al: *Am J Cardiol* 72:677, 1993.

<span id="page-14-2"></span>‡ Tang et al: *J Interv Card Electrophysiol* 22:199, 2008; Patel et al: *Heart Rhythm* 5:253, 2008; Gottlieb et al: *J Cardiovasc Electrophysiol* 19:247, 2008.

<span id="page-14-3"></span>Ohyama et al: *Stroke* 34:2436, 2003.

<span id="page-14-4"></span>Visser et al: *Chest* 83:228–232, 1983; Stratton et al: *Circulation* 66:156–165, 1982.

<span id="page-14-6"></span><span id="page-14-5"></span>¶ Srichai et al: *Am Heart J* 152:75, 2006. Reeder et al: *Mayo Clin Proc* 56:77, 1981.

| Table B.21<br>Diagnosis of Aortic Dissection |     |                         |                      |                      |                                 |                                                       |  |
|----------------------------------------------|-----|-------------------------|----------------------|----------------------|---------------------------------|-------------------------------------------------------|--|
| First Author<br>and Year                     | n   | Approach                | Sensitivity<br>(%)   | Specificity<br>(%)   | Prevalence of<br>Dissection (%) | Standard of Reference                                 |  |
| Victor 1981                                  | 42  | TTE                     | 80                   | 96                   | 36                              | Angiography                                           |  |
| Erbel 1987                                   | 21  | TTE<br>TEE              | 29<br>100            | —                    | 100                             | Surgery or angiography                                |  |
| Hashimoto 1989                               | 22  | TTE<br>TEE<br>CT        | 71<br>100<br>100     | —                    | 100                             | Angiography (17) and/or<br>surgery (12)               |  |
| Ballal 1991                                  | 61  | TEE<br>CT               | 97<br>67             | 100<br>100           | 56                              | Angiography, surgery, or<br>autopsy                   |  |
| Nienaber 1992                                | 53  | TTE<br>TEE<br>CMR       | 83<br>100<br>100     | 63<br>66<br>100      | 58                              | Surgery, autopsy, or<br>angiography                   |  |
| Nienaber 1993                                | 110 | TTE<br>TEE<br>CMR<br>CT | 59<br>98<br>98<br>94 | 83<br>98<br>87<br>83 | 56                              | Surgery (62), autopsy (7),<br>and/or angiography (64) |  |
| Chirillo 1994                                | 70  | TEE                     | 98                   | 97                   | 57                              | Surgery                                               |  |
| Keren 1996                                   | 112 | TEE                     | 98                   | 95                   | 40                              | CT, CMR, aortography,<br>surgery or autopsy           |  |
| Evangelista 1996                             | 13  | TEE                     | 99                   | 100                  | 49                              | Surgery, autopsy, and<br>CMR                          |  |
| Silverman 2000                               | 78  | CMR                     | 100                  | 100                  | 65                              | Surgery                                               |  |
| Yoshida 2003                                 | 45  | CT                      | 100                  | 100                  | 78                              | Surgery                                               |  |

|            |                                          |                                          |                                         | LIKELIHOOD RATIO*                                      |                                                          |
|------------|------------------------------------------|------------------------------------------|-----------------------------------------|--------------------------------------------------------|----------------------------------------------------------|
|            |                                          | Sensitivity (%)                          | Specificity (%)                         | Positive                                               | Negative                                                 |
| Shiga 2006 | 1139 (meta-analysis)<br>TEE<br>CT<br>CMR | 98 (95-99)<br>100 (96-100)<br>98 (95-99) | 95 (92-97)<br>98 (87-99)<br>98 (95-100) | 14.1 (6.0–33.2)<br>13.9 (4.2–46.0)<br>25.3 (11.1–57.1) | 0.04 (0.02–0.08)<br>0.02 (0.01–0.11)<br>0.05 (0.03–0.10) |

<span id="page-15-0"></span><sup>\*</sup>Likelihood ratios greater than 10 and less than 0.1 are considered strong evidence for confirming or ruling out a diagnosis in most clinical settings.

*CMR,* Cardiac magnetic resonance imaging; *CT,* computed tomography. Data from Victor et al: *Am J Cardiol* 48:1155–1159, 1981; Erbel et al: *Br Heart J* 58:45–51, 1987; Hashimoto et al: *J Am Coll Cardiol* 14:1253–1262, 1989; Ballal et al: Circulation 84:1903–1914, 199l; Neinaber et al: *Circulation* 85:434–447, 1992; Neinaber et al: N Engl J Med 328:1–9, 1993; Chirillo et al: *Am J Cardiol* 74:590–595, 1994; Keren et al: *J Am Coll Cardiol* 28:627–636, 1996; Evangelista et al: J Am Coll Cardiol 27:102–107, 1996; Silverman et al: *Int J Card* Imaging 16:461–470, 2000; Yoshida et al: *Radiology* 22:8430–8435, 2003; Shiga et al: *Arch Intern Med* 10:166(13):1350–1356, 2006.